Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants.
Apoptotic cells (AC) are rapidly engulfed by professional phagocytes such as macrophages to avoid secondary necrosis and thus inflammation. Recognition of AC polarizes macrophages toward an anti-inflammatory phenotype, which shows homology to an alternatively activated M2 macrophage. However, mechanistic details provoking these phenotype alterations are incompletely understood. Here, we demonstrate a biphasic up-regulation of heme oxygenase-1 (HO-1), a protein that bears an antiapoptotic as well as an anti-inflammatory potential, in primary human macrophages, which were exposed to the supernatant of AC. Although the first phase of HO-1 induction at 6 h was accomplished by AC-derived sphingosine-1-phosphate (S1P) acting via S1P receptor 1, the second wave of HO-1 induction at 24 h was attributed to autocrine signaling of vascular endothelial growth factor A (VEGFA), whose expression and release were facilitated by S1P. Whereas VEGFA release from macrophages was signal transducer and activator of transcription (STAT) 1-dependent, vascular endothelial growth factor itself triggered STAT1/STAT3 heterodimer formation, which bound to and activated the HO-1 promoter. Knockdown of HO-1 proved its relevance in facilitating enhanced expression of the antiapoptotic proteins Bcl-2 and Bcl-X(L), as well as the anti-inflammatory adenosine receptor A(2A). These findings suggest that HO-1, which is induced by AC-derived S1P, is critically involved in macrophage polarization toward an M2 phenotype.
Weis
Nicole
N
Goethe-University, Institute of Biochemistry I/ZAFES, 60590 Frankfurt, Germany.
Weigert
Andreas
A
von Knethen
Andreas
A
Brüne
Bernhard
B
D017209:Apoptosis; D019898:Autocrine Communication; D002478:Cells, Cultured; D017077:Culture Media, Conditioned; D051547:Heme Oxygenase-1 / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D019169:Jurkat Cells; D008246:Lysophospholipids / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D008262:Macrophage Activation / Q000235:genetics / Q000502:physiology*; D008264:Macrophages / Q000378:metabolism; D008954:Models, Biological; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D049349:Receptors, Lysosphingolipid / Q000378:metabolism; D050794:STAT1 Transcription Factor / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D050796:STAT3 Transcription Factor / Q000378:metabolism / Q000502:physiology; D015398:Signal Transduction; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D015854:Up-Regulation; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000378:metabolism*; D051020:bcl-X Protein / Q000378:metabolism
C494811:BCL2L1 protein, human; D017077:Culture Media, Conditioned; D008246:Lysophospholipids; D019253:Proto-Oncogene Proteins c-bcl-2; D049349:Receptors, Lysosphingolipid; D050794:STAT1 Transcription Factor; C494079:STAT1 protein, human; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D051020:bcl-X Protein; C060506:sphingosine 1-phosphate; D051547:Heme Oxygenase-1; D013110:Sphingosine